Who is sponsoring NCT05246410?

NCT05246410 is sponsored by Acotec Scientific Co., Ltd.

What drugs are being tested in NCT05246410?

Interventions in NCT05246410: Spot stent system, Self-expanding peripheral stent system.

What condition does NCT05246410 study?

NCT05246410 studies Peripheral Vascular Disease (PVD), Peripheral Arterial Disease (PAD).

Is NCT05246410 still recruiting?

NCT05246410 is currently status unknown. Last updated 29 November 2023.

Last reviewed 2023-11-29 · How we verify

NCT05246410

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Clinical Trial to Evaluate the Efficacy and Safety of a Spot Stent System Used in Femoropopliteal Arteries.

Status unknown NA Last updated 29 November 2023

What this trial tests

NA trial testing Spot stent system in Peripheral Vascular Disease (PVD) in 196 participants. Status unknown.

Timeline

17 August 2022

Primary endpoint
28 November 2024

30 December 2024

Quick facts

Lead sponsor	Acotec Scientific Co., Ltd
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	196
Start date	17 August 2022
Primary completion	28 November 2024
Estimated completion	30 December 2024
Sites	2 locations across China

Drugs / interventions tested

Spot stent system
Self-expanding peripheral stent system

Conditions studied

Peripheral Vascular Disease (PVD) — all drugs for Peripheral Vascular Disease (PVD) →
Peripheral Arterial Disease (PAD) — all drugs for Peripheral Arterial Disease (PAD) →

Sponsor

Acotec Scientific Co., Ltd

Who can join

Adults 18 to 80, any sex, with Peripheral Vascular Disease (PVD) or Peripheral Arterial Disease (PAD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective randomized trial designed to compare the efficacy and safety of spot stent system versus self-expanding peripheral stent system in the endovascular treatment of femoropopliteal arterial stenotic disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Acotec Scientific Co., Ltd trials

Trials by the same sponsor.

NCT04885985 — ACOART BTK RENEW：A Post Market Clinical Study · NA · recruiting
NCT04899583 — ACOART SCB BIF: Treatment of Coronary Bifurcation Lesion by Sirolimus Coated Balloon vs Paclitaxel Coated Balloon · NA · unknown
NCT04631055 — AcoArt sICAS: DCB in the Treatment of Symptomatic Intracranial Atherosclerotic Stenosis · NA · completed
NCT04627870 — ACOART Intracranial ISR Pilot:Intracranial DCB in the Treatment of Intracranial In-stent Restenosis · NA · recruiting
NCT04658901 — ACOART RF CLOSURE:Radiofrequency for Varicose Veins of Lower Extremity in China · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05246410 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Acotec Scientific Co., Ltd
Last refreshed: 29 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05246410.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing